These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 10500761

  • 21. Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse.
    Chen H, Qi S, Xu D, Fitzsimmons WE, Bekersky I, Sehgal SN, Daloze P.
    Transplant Proc; 1998 Sep; 30(6):2579-81. PubMed ID: 9745497
    [No Abstract] [Full Text] [Related]

  • 22. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW, HogenEsch H, Heineman E, Jeekel J, Marquet RL.
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract] [Full Text] [Related]

  • 23. Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation.
    Llull R, Murase N, Ye Q, Demetris AJ, Starzl TE.
    Transplant Proc; 1997 Dec; 29(1-2):1203-4. PubMed ID: 9123273
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation.
    Gasser M, Timmermann W, Vowinkel T, Tykal K, Hoppe H, Otto C, Gassel AM, Meyer D, Ulrichs K, Thiede A.
    Transplant Proc; 1998 Sep; 30(6):2605-6. PubMed ID: 9745510
    [No Abstract] [Full Text] [Related]

  • 28. NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation.
    Frezza EE, Gerunda GE, Fassina A, DeFranchis R, Biffi R, Gurakar A, Fagiuoli S, Maffei FA, Van Thiel DH.
    Transplant Proc; 1994 Jun; 26(3):1626. PubMed ID: 8030063
    [No Abstract] [Full Text] [Related]

  • 29. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF, Xiao F, Kociss K, Chong AS, Sankary HN, McChesney L, Cohn S, Williams JW.
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract] [Full Text] [Related]

  • 30. Immune responses during small-intestinal allograft rejection: correlation between procoagulant activity and histopathology.
    Kim PO, Levy GA, Craig M, Cullen J, Cohen Z.
    Transplant Proc; 1990 Dec; 22(6):2477-9. PubMed ID: 2264117
    [No Abstract] [Full Text] [Related]

  • 31. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF, Fukuzawa M, Azuma T, Okada A.
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract] [Full Text] [Related]

  • 32. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
    Fecteau A, Tchervenkov J, Guttman FM, Rosenmann E.
    Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
    [No Abstract] [Full Text] [Related]

  • 33. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion.
    Murase N, Ye Q, Lee RG, Demetris AJ, Abu-Elmagd K, Reyes J, Starzl TE.
    Transplant Proc; 1999 Jun; 31(1-2):565-6. PubMed ID: 10083238
    [No Abstract] [Full Text] [Related]

  • 34. Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
    Tice DG, Bruch D, Ikramuddin S.
    Transplant Proc; 1996 Oct; 28(5):2496. PubMed ID: 8907920
    [No Abstract] [Full Text] [Related]

  • 35. Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.
    Otto C, Gasser M, Gassel HJ, Steger U, Timmermann W, Meyer D, Ulrichs K, Thiede A.
    Transplant Proc; 1998 Aug; 30(5):2161-2. PubMed ID: 9723426
    [No Abstract] [Full Text] [Related]

  • 36. Rejection rate of a small bowel allografts is reduced by liver transplantation.
    Meyer D, Gassel HJ, Timmermann W, Otto C, Ulrichs K, Thiede A.
    Transplant Proc; 2000 Sep; 32(6):1287. PubMed ID: 10995950
    [No Abstract] [Full Text] [Related]

  • 37. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G, McAlister VC, Lee TD, Bitter-Suermann H, Theal M, Wright J, MacDonald AS.
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract] [Full Text] [Related]

  • 38. Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation.
    Ye Q, Demetris AJ, Galvao FH, Toyama Y, Doughton CS, Todo S, Starzl TE, Murase N.
    Transplant Proc; 1996 Oct; 28(5):2453. PubMed ID: 8907895
    [No Abstract] [Full Text] [Related]

  • 39. Cytoimmunologic monitoring of small bowel allograft recipients.
    Graeb C, Stangl MJ, Mebert H, Fischer T, Hammer C.
    Transplant Proc; 1992 Jun; 24(3):1153-4. PubMed ID: 1376515
    [No Abstract] [Full Text] [Related]

  • 40. Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats.
    Yoshida S, Toyama Y, Aoki T, Nakamura J, Odaira H, Inagaki Y.
    Transplant Proc; 2000 Nov; 32(7):2492-3. PubMed ID: 11120262
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.